Global Long-acting Reversible Contraceptives (LARCs) Market Growth 2022-2028
As the global economy mends, the 2021 growth of Long-acting Reversible Contraceptives (LARCs) will have significant change from previous year. According to our researcher latest study, the global Long-acting Reversible Contraceptives (LARCs) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Long-acting Reversible Contraceptives (LARCs) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Long-acting Reversible Contraceptives (LARCs) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Long-acting Reversible Contraceptives (LARCs) market, reaching US$ million by the year 2028. As for the Europe Long-acting Reversible Contraceptives (LARCs) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Long-acting Reversible Contraceptives (LARCs) players cover Bayer, Merck, Cooper Companies, and AbbVie Allergan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Reversible Contraceptives (LARCs) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Hormonal Intrauterine Devices
Copper Intrauterine Devices
Contraceptive Implants
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Age 20-24
Age 25-34
Age 35-44
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON
The United States Long-acting Reversible Contraceptives (LARCs) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Long-acting Reversible Contraceptives (LARCs) market, reaching US$ million by the year 2028. As for the Europe Long-acting Reversible Contraceptives (LARCs) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Long-acting Reversible Contraceptives (LARCs) players cover Bayer, Merck, Cooper Companies, and AbbVie Allergan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Reversible Contraceptives (LARCs) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Hormonal Intrauterine Devices
Copper Intrauterine Devices
Contraceptive Implants
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Age 20-24
Age 25-34
Age 35-44
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
